免疫血小板缺血悖论:我们应该担心ITP中的血栓形成吗?
Artur Saldanha1, Marina Pereira Colella2, Paula Ribeiro Villaça3
1Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), Brazil; Hematology and Hemotherapy Center of Alagoas (HEMOAL), Brazil.
Thrombosis research
|August 13, 2024
概括
患有免疫性血小板缺血 (ITP) 的患者面临出血和血栓形成的双重风险. 较新的疗法提供了更安全的选择,强调对ITP中血栓事件的管理进行仔细的风险评估.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
背景情况:
- 免疫性血栓缩症 (ITP) 患者有出血倾向,但也有动脉和静脉血栓形成的风险增加.
- 在ITP中血栓形成的风险与年龄和心血管风险因素相关,导致显著的发病率.
研究的目的:
- 审查ITP中血栓形成的复杂性质.
- 探索新的病理机制,与血栓形成风险的治疗关联,以及新的治疗方法.
- 解决平衡出血和血栓形成风险的挑战,并管理ITP中的血栓事件.
主要方法:
- 这篇叙述性综述综合了当前关于免疫性血栓缺陷中血栓形成的文献.
- 专注于病理机制,治疗影响和新的治疗策略.
- 探讨了血栓事件风险评估和管理方面的挑战.
主要成果:
- 已建立的治疗方法,如脊髓切除术和血栓形成素受体激动剂 (TPO-RAs),增加了血栓形成的风险,特别是在老年患者或具有危险因素的患者中.
- 替代疗法包括利图西马布,达普松和福斯塔马提尼布没有增加血栓形成的风险.
- 福斯塔马提尼布显示出特别低的血栓形成风险概况.
结论:
- 谨慎的风险评估对于选择ITP治疗,特别是二线选择至关重要.
- 新出现的ITP疗法似乎不会增加血栓形成的风险.
- 需要基于证据的策略来预防和治疗ITP患者的血栓形成,考虑到血小板计数在预测风险方面的不可靠性.
相关概念视频
01:24Disorders of Hemostasis
758
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
758
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:24Tissue Transplantation
350
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
350
01:29Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
501
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
501
02:45Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K